Meta-analysis results for all treatments

Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method

Treament Trials      
clinical improvementclinical worseningdeathsPCR-negative conversion
Immunosuppressants drugs5 1.15 [0.90; 1.47], 1 RCT, I2=0%
inconclusive result
0.69 [0.45; 1.07], 3 RCTs, I2=35%
inconclusive result
1.06 [0.40; 2.84], 2 RCTs, I2=0%
inconclusive result
-
Immunostimulants drugs4- 2.29 [0.20; 26.58], 1 RCT, I2=0%
inconclusive result
1.04 [0.66; 1.63], 1 RCT, I2=0%
inconclusive result
6.33 [1.54; 26.00], 1 RCT, I2=0%
unassessable degree of certainty
A EFFACER anticorps0----
acalabrutinib0----
anti-inflammatory therapies0----
Apilimod0----
corticosteroids0----
imatinib0----
leflunomide0----
pirfenidone0----
Polyinosinic-Polycytidylic Acid0----
sargramostim0----
thymosin0----